JPRN-UMIN000006082招募中未知
A multicenter trial of alogliptin for the safety and efficacy on glycemic control in Japanese type 2 diabetic patients undergoing hemodialysis - Alogliptin in type 2 diabetic patients undergoing hemodialysis
Tokyo Women's Medical University0 个研究点目标入组 30 人开始时间: 2011年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Type 1 diabetic patients 2) Patients with insulin dose equal to or greater than 15 unit per day 3) Patients with liver disease 4) Patients with cancer disease 5) Patients with inflammatory disease 6) patients considered as inadequate by the principal investigator
研究者
相似试验
已完成
3 期
Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsDiabetes MellitusNCT00707993Takeda441
已完成
3 期
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT00856284Takeda2,639
已完成
3 期
Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2NCT01023581Takeda784
已完成
2 期
Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.Diabetes MellitusNCT00755846Takeda265
已完成
不适用
Evaluation of efficacy and safety of Alogliptin in type 2 diabetic patients with chronic kidney diseaseType 2 Diabetic Patients with chronic kidney DiseaseJPRN-UMIN000008133Department of Internal Medicine, Division of Nephrology, Juntendo University Faculty of Medicine50